Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$122.71 - $146.91 $70,067 - $83,885
-571 Reduced 7.33%
7,221 $1.03 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $191,047 - $254,306
1,871 Added 31.6%
7,792 $1 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $84,619 - $101,653
964 Added 19.45%
5,921 $612,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $216,982 - $476,102
2,386 Added 92.8%
4,957 $450,000
Q2 2023

Aug 21, 2023

SELL
$155.98 - $172.65 $195,598 - $216,503
-1,254 Reduced 32.78%
2,571 $416,000
Q1 2023

May 11, 2023

SELL
$132.34 - $159.14 $5.7 Million - $6.85 Million
-43,070 Reduced 91.84%
3,825 $608,000
Q4 2022

Feb 13, 2023

SELL
$102.55 - $135.33 $308,675 - $407,343
-3,010 Reduced 6.03%
46,895 $6.35 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $40,494 - $49,695
-425 Reduced 0.84%
49,905 $4.97 Million
Q2 2022

Aug 11, 2022

SELL
$103.24 - $121.81 $31,384 - $37,030
-304 Reduced 0.6%
50,330 $5.61 Million
Q1 2022

May 13, 2022

SELL
$93.1 - $112.54 $300,061 - $362,716
-3,223 Reduced 5.98%
50,634 $5.62 Million
Q4 2021

Mar 11, 2022

BUY
$95.88 - $117.08 $317,075 - $387,183
3,307 Added 6.54%
53,857 $6.03 Million
Q3 2021

Nov 10, 2021

BUY
$84.42 - $106.62 $239,583 - $302,587
2,838 Added 5.95%
50,550 $4.85 Million
Q1 2021

Apr 21, 2021

SELL
$67.06 - $75.82 $245,171 - $277,197
-3,656 Reduced 7.12%
47,712 $3.22 Million
Q4 2020

Feb 12, 2021

BUY
$63.89 - $73.8 $140,366 - $162,138
2,197 Added 4.47%
51,368 $3.59 Million
Q3 2020

Oct 30, 2020

SELL
$63.69 - $70.22 $8,980 - $9,901
-141 Reduced 0.29%
49,171 $3.41 Million
Q2 2020

Aug 12, 2020

BUY
$58.54 - $67.94 $19,025 - $22,080
325 Added 0.66%
49,312 $3.23 Million
Q1 2020

May 13, 2020

SELL
$49.46 - $64.78 $8,853 - $11,595
-179 Reduced 0.36%
48,987 $2.95 Million
Q4 2019

Feb 12, 2020

SELL
$49.86 - $58.26 $31,910 - $37,286
-640 Reduced 1.28%
49,166 $2.85 Million
Q3 2019

Nov 13, 2019

BUY
$47.54 - $53.43 $234,467 - $263,516
4,932 Added 10.99%
49,806 $2.58 Million
Q2 2019

Aug 14, 2019

BUY
$46.79 - $52.47 $1,778 - $1,993
38 Added 0.08%
44,874 $2.29 Million
Q1 2019

May 15, 2019

BUY
$46.36 - $52.63 $6,397 - $7,262
138 Added 0.31%
44,836 $2.35 Million
Q4 2018

Feb 13, 2019

SELL
$41.54 - $47.25 $28,911 - $32,886
-696 Reduced 1.53%
44,698 $2.06 Million
Q3 2018

Nov 13, 2018

BUY
$46.76 - $51.24 $33,059 - $36,226
707 Added 1.58%
45,394 $2.14 Million
Q2 2018

Aug 13, 2018

SELL
$44.29 - $50.42 $14,172 - $16,134
-320 Reduced 0.71%
44,687 $2.06 Million
Q1 2018

May 14, 2018

BUY
$48.49 - $58.14 $60,903 - $73,023
1,256 Added 2.87%
45,007 $2.22 Million
Q4 2017

Feb 14, 2018

BUY
$47.53 - $53.73 $355,144 - $401,470
7,472 Added 20.6%
43,751 $2.35 Million
Q3 2017

Nov 14, 2017

SELL
$41.15 - $49.22 $452 - $541
-11 Reduced 0.03%
36,279 $1.75 Million
Q2 2017

Aug 14, 2017

BUY
N/A
36,290
36,290 $1.56 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $246B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bokf, Na Portfolio

Follow Bokf, Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.